Status:
COMPLETED
Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression
Lead Sponsor:
McMaster University
Conditions:
Major Depressive Disorder
Insomnia
Eligibility:
FEMALE
40-60 years
Phase:
PHASE4
Brief Summary
The study was designed to examine the efficacy and tolerability of quetiapine XR for the treatment of women who suffer from depression in the context of the menopausal transition and postmenopausal ye...
Detailed Description
The menopause transition (or perimenopause) and the early postmenopausal years are marked by intense hormone fluctuations; hormone changes are frequently accompanied by the occurrence hot flashes, nig...
Eligibility Criteria
Inclusion
- women 40 to 60 years
- diagnosis of MDD
- perimenopausal or postmenopausal
Exclusion
- using HRT
- using psychotropic medications
- other DSM-IV axis I diagnoses other than MDD
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00723970
Start Date
June 1 2007
End Date
May 1 2009
Last Update
February 8 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women's Health Concerns Clinic (WHCC)
Hamilton, Ontario, Canada, L8P 3B6